about
Endotoxemia-mediated inflammation potentiates aminoglycoside-induced ototoxicity.Long term streptomycin toxicity in the treatment of Buruli Ulcer: follow-up of participants in the BURULICO drug trial.Neomycin-induced hair cell death and rapid regeneration in the lateral line of zebrafish (Danio rerio).Mutational analysis of the mitochondrial 12S rRNA gene in Chinese pediatric subjects with aminoglycoside-induced and non-syndromic hearing loss.A modern approach to the treatment of mitochondrial diseasePharmacogenetics and the future of medical practice.Pharmacogenetics and pharmacogenomics in drug discovery and development: an overview.Clinical aspects of hereditary hearing loss.Susceptibility genes for gentamicin-induced vestibular dysfunction.Small Compartment Toxicity: CN VIII and Quality of Life: Hearing Loss, Tinnitus, and Balance Disorders.The deafness gene DFNA5 induces programmed cell death through mitochondria and MAPK-related pathwaysThe chaperone network connected to human ribosome-associated complexLack of a modulative factor in locus 8p23 in a Finnish family with nonsyndromic sensorineural hearing loss associated with the 1555A>G mitochondrial DNA mutation.Management of aminoglycosides in the intensive care unit.Ototoxic interaction of kanamycin and 3-nitropropionic acid.Modifier locus for mitochondrial DNA disease: linkage and linkage disequilibrium mapping of a nuclear modifier gene for maternally inherited deafness.Antibiotic susceptibility of mammalian mitochondrial translation.Considerations for a multiaxis nomenclature system for medical genetics.
P2860
Q27324803-38615B6D-3D5D-44AB-8E1D-495558B233D2Q28540814-7F7ED757-98B2-4BA1-9C2E-BA7BAEC35CACQ30473445-40A9331F-3B54-453F-9997-3285DBB1ED39Q34703553-23B06795-B418-4D9C-850E-4946C3318AFCQ35011397-D335629F-A12D-4BA2-BD41-42AABD1C3E31Q35102207-6F33DDE8-55FB-4B6A-8000-1C511D7AD76AQ35127754-E870FD2A-6C83-48BC-B470-C0F769A30C6DQ36897916-5C486055-A4F2-4E62-8DAF-93E1D115DC77Q36969106-ECFAA142-1262-4C52-A3BE-2B7786F2B74BQ38838058-FA4E31BE-BFC6-4177-ADF6-343454B7D75BQ40667234-5063BE2F-ADBF-470E-B601-76B640B54E4BQ42083091-E39A7FDB-1155-4E44-BC24-CFDFD92096B9Q42606914-427AA26E-3A44-4333-BEE4-0B2953F2E596Q42908869-CCA17183-0931-4FF9-87E7-8610E8E9250BQ46496583-31AF8167-4756-41D7-80D4-3F5A2A41300CQ46764503-EC3F663B-1AA1-427B-A0CC-0573F78FC7E2Q46791953-2FB84279-4E35-4DEF-B41E-63ECE67A2552Q48738408-BFFC9E78-DE1E-4D98-B042-42AA65E1ED4C
P2860
description
1999 nî lūn-bûn
@nan
1999 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Genetic factors in aminoglycoside toxicity.
@ast
Genetic factors in aminoglycoside toxicity.
@en
type
label
Genetic factors in aminoglycoside toxicity.
@ast
Genetic factors in aminoglycoside toxicity.
@en
prefLabel
Genetic factors in aminoglycoside toxicity.
@ast
Genetic factors in aminoglycoside toxicity.
@en
P2860
P1476
Genetic factors in aminoglycoside toxicity.
@en
P2093
Fischel-Ghodsian N
P2860
P304
P356
10.1111/J.1749-6632.1999.TB08639.X
P407
P577
1999-11-01T00:00:00Z